Both in Pharmaceuticals
Royalty Pharma vs Jazz Pharmaceuticals
Over the past year RPRX returned +71.4% and JAZZ returned +54.5%; their daily moves had a correlation of 0.30.
RPRX +71.4% JAZZ +54.5%Growth of $1, one year, split-adjusted
| Metric | RPRX | JAZZ |
|---|---|---|
| Price | $63.86 | $214.00 |
| Market cap | $28.44B | $13.89B |
| Today | +0.17% | −0.30% |
| 1 month | +9.6% | −9.4% |
| 6 months | +29.3% | +8.9% |
| Year to date | +65.3% | +25.9% |
| 1 year | +73.3% | +54.5% |
| Revenue growth (YoY) | +16.5% | +15.5% |
| Gross margin | 100.0% | 90.4% |
| Net margin | 2.7% | 16.0% |
| P/E (TTM) | 34.9× | 14.8× |
| Price / sales | 11.2× | 3.0× |
| Net cash | -$8.23B | -$2.15B |
| Dividend yield | 1.47% | — |
| Volatility (60d) | 24.9% | 27.1% |
| Short % of float | 2.9% | 8.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).